TY - JOUR
T1 - Corrigendum
T2 - Is Candida auris here to stay? An interview with Dimitrios Kontoyiannis (Future Microbiology (2019) 14:13 (1083-1085) DOI: 10.2217/fmb-2019-0210)
AU - Kontoyiannis, Dimitrios P.
PY - 2019/1/1
Y1 - 2019/1/1
N2 - The interview by Dimitrios P Kontoyiannis, 'Is Candida auris here to stay? An interview with Dimitrios Kontoyiannis', which appeared in the September 2019 issue of FutureMicrobiology 14(13), 1083-1085 (2019), was published with an inaccuracy suggesting Clostridium difficile is carbapenemase resistant. The corrected sentence should read 'Its resistance nature andresilience in the hospital environment is not unlike that of carbapenemase-resistant bacteria or Clostridium difficile, in how they create infection control nightmares'. This has now been corrected. The authors and editors of FutureMicrobiology would like to sincerely apologize for any inconvenience or confusion this may have caused our readers.
AB - The interview by Dimitrios P Kontoyiannis, 'Is Candida auris here to stay? An interview with Dimitrios Kontoyiannis', which appeared in the September 2019 issue of FutureMicrobiology 14(13), 1083-1085 (2019), was published with an inaccuracy suggesting Clostridium difficile is carbapenemase resistant. The corrected sentence should read 'Its resistance nature andresilience in the hospital environment is not unlike that of carbapenemase-resistant bacteria or Clostridium difficile, in how they create infection control nightmares'. This has now been corrected. The authors and editors of FutureMicrobiology would like to sincerely apologize for any inconvenience or confusion this may have caused our readers.
UR - http://www.scopus.com/inward/record.url?scp=85077440789&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85077440789&partnerID=8YFLogxK
U2 - 10.2217/fmb-2019-0210c1
DO - 10.2217/fmb-2019-0210c1
M3 - Comment/debate
C2 - 31859567
AN - SCOPUS:85077440789
SN - 1746-0913
VL - 14
JO - Future Microbiology
JF - Future Microbiology
IS - 15
ER -